V Square Quantitative Management LLC Increases Stake in MetLife, Inc. $MET

Key Points

• V Square Quantitative Management LLC increased its stake in MetLife, Inc. by 288.6% during the second quarter, owning a total of 30,340 shares valued at approximately $2.44 million.
• MetLife's stock rose 1.7% recently, with a current market cap of $54.27 billion and a twelve-month price range from $65.21 to $89.05.
• The company reported earnings of $2.02 per share for the last quarter, which fell short of analysts' expectations, alongside a revenue of $17.34 billion, indicating a 2.7% year-over-year decline.

V Square Quantitative Management LLC boosted its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 288.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 30,340 shares of the financial services provider's stock after purchasing an additional 22,533 shares during the quarter. V Square Quantitative Management LLC's holdings in MetLife were worth $2,440,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of MET. Diamond Hill Capital Management Inc. purchased a new stake in MetLife in the first quarter worth about $336,965,000. Nuveen LLC purchased a new stake in MetLife in the first quarter worth about $312,946,000. Price T Rowe Associates Inc. MD grew its holdings in MetLife by 7.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,488,146 shares of the financial services provider's stock worth $2,126,734,000 after purchasing an additional 1,824,907 shares during the period. Alyeska Investment Group L.P. purchased a new stake in MetLife in the first quarter worth about $68,030,000. Finally, GAMMA Investing LLC grew its holdings in MetLife by 8,789.6% in the first quarter. GAMMA Investing LLC now owns 815,889 shares of the financial services provider's stock worth $65,508,000 after purchasing an additional 806,711 shares during the period. Hedge funds and other institutional investors own 94.99% of the company's stock.

MetLife Stock Up 1.7%

Shares of MetLife stock opened at $81.61 on Monday. The company has a market cap of $54.27 billion, a price-to-earnings ratio of 13.83, a price-to-earnings-growth ratio of 0.74 and a beta of 0.87. The company's 50 day moving average is $78.67 and its 200 day moving average is $78.14. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The firm's revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter last year, the company earned $2.28 EPS. Research analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th were given a $0.5675 dividend. The ex-dividend date was Tuesday, August 5th. This represents a $2.27 annualized dividend and a yield of 2.8%. MetLife's dividend payout ratio (DPR) is presently 38.47%.

Analyst Ratings Changes

MET has been the topic of a number of recent analyst reports. Cowen reiterated a "buy" rating on shares of MetLife in a report on Friday, August 22nd. Keefe, Bruyette & Woods cut their price target on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a report on Monday, August 11th. Piper Sandler cut shares of MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 price target on the stock. in a report on Friday, September 19th. Wolfe Research upgraded shares of MetLife to a "strong-buy" rating in a report on Tuesday, September 16th. Finally, Morgan Stanley cut their price target on shares of MetLife from $98.00 to $94.00 and set an "overweight" rating on the stock in a report on Monday, August 18th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $94.64.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.